These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33811492)

  • 21. Drug-induced hepatotoxicity.
    Lee WM
    N Engl J Med; 2003 Jul; 349(5):474-85. PubMed ID: 12890847
    [No Abstract]   [Full Text] [Related]  

  • 22. Intensive monitoring of adverse drug events associated with the use of new glucose-lowering drugs: results from an inception cohort study in Portugal.
    Torre C; Guerreiro J; Longo P; Raposo JF; Leufkens H; Martins AP
    Diabet Med; 2020 Apr; 37(4):648-656. PubMed ID: 31692117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine-tuning the most common prescription types.
    Johns Hopkins Med Lett Health After 50; 2000 Jan; 11(11):4-5. PubMed ID: 10614185
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacological management of type 2 diabetes mellitus in patients with CKD.
    Hamilton CA
    J Ren Care; 2012 Feb; 38 Suppl 1():59-66. PubMed ID: 22348365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes and its Complications - Contemporary Treatment and Potential Side Effects of Drugs to Treat Diabetes.
    Vestergaard P
    Curr Drug Saf; 2021; 16(1):1. PubMed ID: 33726642
    [No Abstract]   [Full Text] [Related]  

  • 26. Elderly patients with type 2 diabetes mellitus-the need for high-quality, inpatient diabetes care.
    Bourdel-Marchasson I; Sinclair A
    Hosp Pract (1995); 2013; 41(4):51-6. PubMed ID: 24145589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [INFORMATION ON DRUGS].
    Foucher JP
    J Int Bioethique Ethique Sci; 2015 Mar; 26(1):65-72, 101-2. PubMed ID: 26606769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options.
    Verhaegen AA; Van Gaal LF
    J Endocrinol Invest; 2017 Nov; 40(11):1165-1174. PubMed ID: 28660606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug treatment in the elderly: problems and prescribing rules.
    Briant RH
    Drugs; 1977 Mar; 13(3):225-9. PubMed ID: 14817
    [No Abstract]   [Full Text] [Related]  

  • 30. Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets.
    He JH; Chen LX; Li H
    Fitoterapia; 2019 Apr; 134():270-289. PubMed ID: 30840917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery.
    Zhou K; Pedersen HK; Dawed AY; Pearson ER
    Nat Rev Endocrinol; 2016 Jun; 12(6):337-46. PubMed ID: 27062931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria.
    Yusuff KB; Obe O; Joseph BY
    Pharm World Sci; 2008 Dec; 30(6):876-83. PubMed ID: 18784982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies.
    Chang W; Chen L; Hatch GM
    Biochem Cell Biol; 2015 Oct; 93(5):479-86. PubMed ID: 25607236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do we still need pioglitazone for the treatment of type 2 diabetes? A risk-benefit critique in 2013.
    Schernthaner G; Currie CJ; Schernthaner GH
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S155-61. PubMed ID: 23882041
    [No Abstract]   [Full Text] [Related]  

  • 35. Rosiglitazone: seeking a balanced perspective.
    The Lancet
    Lancet; 2007 Jun; 369(9576):1834. PubMed ID: 17544746
    [No Abstract]   [Full Text] [Related]  

  • 36. Hardships of drugs monitoring - Ambiguities in pharmacovigilance rules 2018 and guidelines 2019 in the Pakistan.
    Abbas N; Jabeen R
    J Pak Med Assoc; 2021 Oct; 71(10):2481-2482. PubMed ID: 34974602
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-diabetic effect of standardized herbal formula PM021 consisting of Mori Folium and Aurantii Fructus on type II diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Kim JH; Chung HS; Kang M; Kim Y; Kim BS; Kim YS; Bae H
    Diabetes Res Clin Pract; 2011 Aug; 93(2):198-204. PubMed ID: 21524812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes.
    Tsapas A; Karagiannis T; Avgerinos I; Matthews DR; Bekiari E
    Ann Intern Med; 2021 Jan; 174(1):141. PubMed ID: 33460545
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes.
    Kabadi UM
    Ann Intern Med; 2021 Jan; 174(1):140. PubMed ID: 33460546
    [No Abstract]   [Full Text] [Related]  

  • 40. ADVERSE DRUG REACTIONS.
    JEFFREY LP
    Hosp Manage; 1964 May; 97():58-64. PubMed ID: 14168607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.